Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00472 | 1-(4-((5-nitropyridin-2-yl)disulfanyl)pentanoyloxy)-2,5-ioxopyrrolidine-3-sulfonic acid | 663598-66-1 |
| Inquiry | ||
| BADC-00473 | 2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate | 663598-61-6 |
| Inquiry | ||
| BADC-00474 | 2,5-dioxo-1-(4-(pyridin-2-yldisulfanyl)pentanoyloxy)pyrrolidine-3-sulfonic acid | 452072-27-4 |
| Inquiry | ||
| BADC-00475 | 1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid | 1193111-37-3 |
| Inquiry | ||
| BADC-00476 | 2,5-dioxopyrrolidin-1-yl 2-(dimethylamino)-4-(pyridin-2-yldisulfanyl)butanoate | 1193111-73-7 |
| Dimethylamine-SPDB is a small molecule biopharmaceutical compound. It inhibits viral replication and pathogenesis by targeting enzymes, demonstrating its prowess as a powerful antagonist of viral infections, including influenza and hepatitis. Furthermore, it holds great promise in the field of oncology, fighting malignant tumors by elastically destroying the growth and proliferation of malignant cells. | Inquiry | |
| BADC-00477 | 1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid | 1193111-39-5 |
| Inquiry | ||
| BADC-00478 | 1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663599-07-3 |
| DMAC-SPDB-sulfo is an effective small molecule reagent. Its efficacy is primarily due to its selective mediation of key enzyme cascades and receptor signaling pathways, which are critical for targeted disease progression. This breakthrough bioactive compound has great potential to intervene in specific diseases. | Inquiry | |
| BADC-00479 | 1-(4-((5-nitropyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663598-89-8 |
| Inquiry | ||
| BADC-00480 | 3-(methylsulfonyl)-2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)butanoate | 890409-86-6 |
| Inquiry | ||
| BADC-00482 | 2,5-dioxo-1-(4-(pyridin-2-yldisulfanyl)butanoyloxy)pyrrolidine-3-sulfonic acid | 1628113-16-5 |
| SPDB-sulfo is a small molecule compound. This compound is effective against bacterial invasion, including pneumonia, respiratory infections, and urinary tract infections. It exhibits its good antibacterial abilities. | Inquiry | |
| BADC-00483 | 2,5-dioxopyrrolidin-1-yl 4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoate | 663599-05-1 |
| DMAC-SPDB is a bioactive compound. It blocks signaling pathways associated with cancer and inflammation, exerting its influence as a targeted enzyme inhibitor. Furthermore, it shows decent proficiency in regulating the harmonious balance of enzymatic reactions associated with metabolic dysfunction. | Inquiry | |
| BADC-00484 | N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate | 663598-85-4 |
| Inquiry | ||
| BADC-00486 | 2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate | 107348-47-0 |
| Inquiry | ||
| BADC-00487 | perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate | 160580-70-1 |
| Inquiry | ||
| BADC-00488 | 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid | 121115-30-8 |
| SPDP-sulfo is a biomedical compound that has demonstrated its ability to combat various diseases. Because of its ability to expertly inhibit the tailor-made enzymes that control the progression of diseases such as cancer and inflammation, it emerges as a potential disease intervention tool. | Inquiry | |
| BADC-00489 | 4-((S)-2-((S)-2-amino-3-methylbutanamido)-5-ureidopentanamido)benzyl 2-(pyridin-2-yldisulfanyl)ethylcarbamate | 1610769-13-5 |
| PDP-C1-Ph-Val-Cit is a small molecule compound. It blocks specific enzymes involved in harmful processes of tumor expansion and metastasis, effectively inhibiting cancer progression. | Inquiry | |
| BADC-00490 | Boc-Phe-(Alloc)Lys-PAB-PNP | 1160844-44-9 |
| Boc-Phe-(Alloc)Lys-PAB-PNP is a complex biomedical compound being investigated as an innovative treatment for a variety of diseases, especially cancer. Known for its powerful properties, it effectively halts tumor progression through targeted neutralization of unique enzymes and pathways. | Inquiry | |
| BADC-00491 | Cbz-Phe-(Alloc)Lys-PAB-PNP | 159857-90-6 |
| Cbz-Phe-(Alloc)Lys-PAB-PNP is an important biomedical chemical product that has emerged as a potential therapeutic agent against various diseases. It has demonstrated outstanding capabilities as a candidate compound for targeted therapy against various malignancies, including breast and prostate cancer. This revolutionary compound, Cbz-Phe-(Alloc)Lys-PAB-PNP, utilizes its unique molecular structure to produce profound inhibitory effects on the proliferation of malignant cells. | Inquiry | |
| BADC-00492 | Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP | 253863-34-2 |
| Inquiry | ||
| BADC-00493 | Fmoc-Ala-Ala-Asn-PAB-PNP | |
| Fmoc-Ala-Ala-Asn-PAB-PNP is an excellent and highly discriminating inhibitor widely used in biomedicine for multiple purposes. It is widely used in the field of drug development, especially in the targeted detection and attenuation of malignancies and cancers. | Inquiry |
